tiprankstipranks
Trending News
More News >
Science Group PLC (GB:SAG)
LSE:SAG
UK Market
Advertisement

Science (SAG) AI Stock Analysis

Compare
4 Followers

Top Page

GB

Science

(LSE:SAG)

Rating:71Outperform
Price Target:
564.00p
▲(3.96%Upside)
The overall stock score is driven by strong financial performance and positive corporate events. However, technical analysis indicates potential risks with an overbought RSI, and valuation metrics suggest the stock is fairly priced. Risks related to the performance of Ricardo, a significant investment, should be monitored.

Science (SAG) vs. iShares MSCI United Kingdom ETF (EWC)

Science Business Overview & Revenue Model

Company DescriptionScience Group plc, together with its subsidiaries, provides science and technology-based consultancy services in the United Kingdom, North America, Europe, and internationally. The company operates through R&D Consultancy; Regulatory & Compliance; and Frontier Smart Technologies divisions. It offers product and technology development, scientific and regulatory advice, and registration and compliance services to medical, food and beverage, consumer, industrial, chemical, and energy sectors. The company also provides property services. In addition, it manufactures and sells chips, and modules, which are incorporated into digital radios. The company was formerly known as Sagentia Group plc and changed its name to Science Group plc in July 2015. Science Group plc was incorporated in 2008 and is headquartered in Cambridge, the United Kingdom.
How the Company Makes MoneySAIC makes money through a variety of revenue streams, primarily through government contracts and service agreements. The company is heavily reliant on long-term contracts with U.S. government agencies, which provide a stable and consistent source of revenue. SAIC's revenue model includes project-based work where they charge for services rendered, as well as managed services and support contracts that offer recurring revenue. Additionally, the company engages in strategic partnerships and alliances to enhance its technological capabilities and expand its market reach, which can contribute to its earnings growth.

Science Financial Statement Overview

Summary
The company exhibits strong financial health with robust income statement metrics and a solid balance sheet. Despite a slight revenue decline recently, the company's effective cost management and strong cash flow generation reflect a sustainable financial position.
Income Statement
85
Very Positive
The company demonstrates strong income statement metrics with consistent revenue growth, as shown by a revenue increase from 2020 to 2023. Gross and net profit margins have been robust, with gross profit margins averaging around 40%. The EBIT margin has shown improvement, indicating effective cost control and operational efficiency. However, revenue slightly declined from 2023 to 2024, which is a point of concern.
Balance Sheet
80
Positive
The balance sheet is solid with a healthy equity ratio of over 50%, indicating a strong financial position. The company maintains a manageable debt-to-equity ratio, showcasing prudent leverage management. Return on Equity (ROE) is also favorable, reflecting effective use of shareholders' equity. The increase in stockholders' equity over time emphasizes financial stability, although the total debt level needs to be monitored.
Cash Flow
78
Positive
The cash flow statement reflects a positive trend in operating cash flow, which has grown significantly from 2019 to 2024. Free cash flow has also been consistently positive, signaling good liquidity and financial flexibility. Despite these strengths, the free cash flow growth rate shows some volatility, which could affect short-term cash management strategies.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue110.67M113.34M86.30M81.22M73.66M
Gross Profit45.18M46.25M38.35M35.36M29.80M
EBITDA21.13M15.15M16.64M16.00M11.62M
Net Income12.02M5.52M10.55M9.56M7.04M
Balance Sheet
Total Assets141.09M132.45M127.28M115.94M92.05M
Cash, Cash Equivalents and Short-Term Investments41.45M32.83M46.51M37.19M29.07M
Total Debt15.49M16.90M16.02M16.88M18.79M
Total Liabilities57.09M54.46M49.08M49.64M50.66M
Stockholders Equity84.00M77.99M78.20M66.29M41.39M
Cash Flow
Free Cash Flow18.48M7.83M15.18M9.15M17.54M
Operating Cash Flow18.48M7.91M15.27M14.01M17.69M
Investing Cash Flow723.00K-12.78M-34.00K-19.08M-134.00K
Financing Cash Flow-10.72M-8.49M-6.46M13.08M-3.53M

Science Technical Analysis

Technical Analysis Sentiment
Positive
Last Price542.50
Price Trends
50DMA
488.43
Positive
100DMA
454.59
Positive
200DMA
453.45
Positive
Market Momentum
MACD
13.95
Positive
RSI
90.62
Negative
STOCH
73.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SAG, the sentiment is Positive. The current price of 542.5 is above the 20-day moving average (MA) of 524.50, above the 50-day MA of 488.43, and above the 200-day MA of 453.45, indicating a bullish trend. The MACD of 13.95 indicates Positive momentum. The RSI at 90.62 is Negative, neither overbought nor oversold. The STOCH value of 73.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:SAG.

Science Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£196.01M22.8045.84%4.01%13.00%11.16%
78
Outperform
£353.88M21.7513.02%1.66%29.64%-7.27%
GBSAG
71
Outperform
£240.90M20.4814.84%1.47%-2.36%117.49%
68
Neutral
£178.25M130.881.85%4.94%4.95%-53.49%
67
Neutral
€2.73B22.487.73%3.01%-1.29%-31.61%
62
Neutral
£263.16M205.36-5.28%0.80%-8.12%-794.85%
GBRWA
55
Neutral
£123.59M29.69-3.96%13.88%-16.16%-145.46%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SAG
Science
542.50
131.69
32.06%
GB:GTLY
Gateley (Holdings)
132.00
4.78
3.76%
GB:RCDO
Ricardo
424.00
-56.52
-11.76%
GB:RWA
Robert Walters
171.00
-184.78
-51.94%
GB:ELIX
Elixirr International Plc
756.00
229.66
43.63%
GB:KEYS
Keystone Law Group Plc
624.00
9.66
1.57%

Science Corporate Events

Stock Buyback
Science Group plc Announces Share Buyback
Neutral
Jul 16, 2025

Science Group plc, a company listed on the AIM market, announced a share buyback transaction where it purchased 5,000 of its ordinary shares at an average price of 546.5 pence per share. This transaction represents 0.01% of the voting rights of the total ordinary shares in issue prior to the purchase, and the shares will be held in treasury. The total number of shares in issue, excluding treasury shares, is now 44,385,426. This figure is relevant for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Executive/Board ChangesFinancial Disclosures
Science Group PLC Appoints New Adviser and Announces Interim Results Date
Neutral
Jul 15, 2025

Science Group PLC has appointed Panmure Liberum Limited as its new Nominated Adviser and sole Broker, effective from 15 July 2025. The company plans to appoint a second Broker in the coming months to return to a joint Broker arrangement. Additionally, Science Group is set to release its Interim Results for the period ending 30 June 2025 on 28 July 2025.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Science Group PLC Executes Share Buyback to Enhance Capital Management
Neutral
Jul 15, 2025

Science Group PLC has executed a share buyback, purchasing 15,000 of its ordinary shares at a price of 539.0 pence each. This transaction represents 0.03% of the company’s voting rights and is part of its ongoing strategy to manage capital and shareholder value. The shares will be held in treasury, and the new total of ordinary shares in issue is 44,390,426. This move may impact shareholder calculations under the FCA’s rules, indicating a strategic approach to enhancing market positioning and shareholder engagement.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Jul 14, 2025

Science Group PLC announced the repurchase of 5,929 of its ordinary shares at a price of 539.5 pence per share, which constitutes 0.01% of the voting rights of the total ordinary shares before the purchase. These shares will be held in treasury, and the total number of shares in issue, excluding treasury shares, is now 44,405,426. This transaction is part of the company’s buyback program, which may impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Jul 11, 2025

Science Group PLC has announced the repurchase of 15,000 of its ordinary shares at an average price of 525.0 pence per share, representing 0.03% of the voting rights. These shares will be held in treasury, adjusting the total number of ordinary shares in issue to 44,411,355. This move is part of the company’s ongoing buyback program, potentially impacting shareholder calculations under the FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Jul 4, 2025

Science Group PLC announced the repurchase of 5,000 ordinary shares at 521.0 pence each, representing 0.01% of the voting rights. These shares will be held in treasury, adjusting the total number of shares in issue to 44,426,355. This transaction is part of the company’s ongoing share buyback program, which could influence shareholder calculations under the FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback Program
Neutral
Jul 2, 2025

Science Group PLC announced the repurchase of 17,000 of its ordinary shares at an average price of 522.5 pence per share, representing 0.04% of the voting rights. This transaction is part of a buyback program facilitated by Panmure Liberum Limited, with the purchased shares held in treasury. The move affects the total number of ordinary shares in issue, now standing at 44,431,355, and provides shareholders with a new denominator for interest calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Jul 1, 2025

Science Group PLC has repurchased 15,500 of its ordinary shares at a consistent price of 525.0 pence per share, representing 0.03% of the voting rights. This transaction, executed through Panmure Liberum Limited, adjusts the total number of shares in issue to 44,448,355, excluding treasury shares, and is part of the company’s ongoing buyback program, which could impact shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Jun 27, 2025

Science Group PLC has announced a share buyback transaction, purchasing 15,000 of its ordinary shares at an average price of 522.0 pence per share. This transaction represents 0.03% of the voting rights of the total ordinary shares in issue before the purchase. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,463,855. This move may impact shareholder calculations regarding their interests in the company as per FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Jun 26, 2025

Science Group PLC announced the repurchase of 15,000 of its ordinary shares at a consistent price of 525.0 pence per share, representing 0.03% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s buyback program, and the shares will be held in treasury. The total number of shares in issue, excluding treasury shares, is now 44,478,855. This move could potentially impact shareholder calculations under the FCA’s rules, indicating a strategic financial maneuver to manage the company’s share capital.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Science Group PLC Announces Share Buyback
Neutral
Jun 24, 2025

Science Group PLC has announced the repurchase of 15,500 of its ordinary shares at an average price of 514.75 pence per share, representing 0.03% of the voting rights. These shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,493,855. This buyback is part of the company’s ongoing strategy to manage its capital structure and may impact shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Jun 23, 2025

Science Group PLC has announced the repurchase of 10,000 of its ordinary shares at an average price of 514.9 pence per share, with the transaction executed through Panmure Liberum Limited. This buyback represents a small fraction of the company’s total voting rights and is part of its ongoing treasury management strategy, potentially impacting shareholder calculations under the FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and Strategy
Science Group PLC Announces Major Change in Voting Rights
Neutral
Jun 20, 2025

Science Group PLC, a UK-based company, has announced a significant change in its voting rights structure. Canaccord Genuity Group Inc., based in Vancouver, Canada, has reduced its voting rights in Science Group PLC from 9.8683% to 4.9888% as of June 18, 2025. This adjustment in holdings indicates a strategic shift that may influence the company’s governance and decision-making processes, potentially impacting stakeholders and market perceptions.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackFinancial Disclosures
Science Group Sells Ricardo Stake, Boosts Share Buy-Back
Neutral
Jun 19, 2025

Science Group PLC has announced the sale of its entire holding in Ricardo plc, resulting in a net return of approximately £23.7 million after brokerage fees and related costs. The company plans to use the proceeds to increase its share buy-back authorization, managed by Panmure Liberum Limited, and anticipates releasing its interim results for the period ending 30 June 2025 by the end of July.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Jun 17, 2025

Science Group PLC has announced the repurchase of 10,000 of its ordinary shares at a price of 511.0 pence per share, which represents 0.02% of the voting rights of the total ordinary shares prior to the purchase. This transaction is part of the company’s ongoing buyback program, and the shares will be held in treasury, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

M&A TransactionsBusiness Operations and Strategy
Science Group Profits from Ricardo Share Sale to WSP
Positive
Jun 11, 2025

Science Group PLC has announced the sale of a significant portion of its shares in Ricardo plc to WSP Group Limited, resulting in a substantial profit. The transaction will generate approximately £53.5 million in cash proceeds, which Science Group plans to use for future strategic investments. The sale supports WSP’s offer for Ricardo, providing a 102% premium over Ricardo’s previous share price, benefiting all shareholders involved.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Jun 5, 2025

Science Group PLC announced the repurchase of 5,000 of its own shares at a price of 463.0 pence per share, representing 0.01% of the voting rights. These shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,529,355. This move is part of the company’s ongoing buyback program, which could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Jun 4, 2025

Science Group PLC has repurchased 5,000 of its ordinary shares at an average price of 463.5 pence per share, representing 0.01% of the voting rights. This transaction, conducted through Panmure Liberum Limited, is part of the company’s share buyback program and impacts the total number of shares in issue, which now stands at 44,534,355, excluding treasury shares.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Jun 3, 2025

Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 463.5 pence each, representing 0.01% of its voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program, impacting the total number of shares in issue and potentially affecting shareholder calculations under regulatory guidelines.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
ISS Recommends Removal of Ricardo Chairman Amid Performance Concerns
Negative
Jun 2, 2025

Science Group PLC has announced that ISS, an independent proxy agency, has recommended voting in favor of removing Ricardo plc’s Chairman, Mr. Mark Clare, due to the company’s ongoing poor performance and ineffective strategy implementation. Science Group supports this recommendation and encourages Ricardo shareholders to vote for the resolution at the upcoming General Meeting, highlighting concerns about Ricardo’s performance and its relative underperformance compared to peers.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group PLC Announces Total Voting Rights
Neutral
Jun 2, 2025

Science Group PLC has announced its total issued share capital, excluding treasury shares, consists of 44,544,355 shares of 1 penny each, with 1,641,519 shares held in treasury. This figure is crucial for shareholders as it serves as the denominator for calculating their interests or changes in interests in the company, in compliance with the FCA’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Science Group Increases Stake in Ricardo, Calls for Leadership Change
Negative
May 28, 2025

Science Group PLC has increased its investment in Ricardo plc to 21.8% of the voting rights, following concerns over Ricardo’s poor performance and governance issues. The company has called for a general meeting to vote on the removal of Ricardo’s Chairman, aiming to initiate changes that align with shareholder interests and improve Ricardo’s performance.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
May 23, 2025

Science Group PLC has repurchased 4,500 of its ordinary shares at a price of 464.0 pence each, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program and will see the shares held in treasury, impacting the total number of shares available for shareholder calculations under regulatory guidelines.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Science Group PLC Executes Share Buyback Program
Neutral
May 22, 2025

Science Group PLC announced the purchase of 2,500 of its ordinary shares at a price of 477.0 pence per share, representing 0.01% of the voting rights before the purchase. These shares will be held in treasury, affecting the total number of shares in issue, which now stands at 44,548,855. This transaction is part of the company’s ongoing strategy to manage its capital structure and potentially increase shareholder value.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Shareholder MeetingsDividendsFinancial Disclosures
Science Group PLC Successfully Passes All AGM Resolutions
Positive
May 21, 2025

Science Group PLC announced that all resolutions at their Annual General Meeting were passed, including the adoption of financial statements for 2024, reappointment of auditors, and approval of a final dividend of 8.0 pence per share. This successful meeting reflects strong shareholder support and positions the company for continued stability and growth, benefiting stakeholders by reinforcing its market presence and operational strategies.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Shareholder MeetingsBusiness Operations and StrategyFinancial Disclosures
Science Group PLC Reports Strong Start and Strategic Engagement with Ricardo PLC
Positive
May 21, 2025

Science Group PLC reports a strong start to the year with revenue and profitability exceeding expectations despite global volatility. The company has successfully completed an IT system migration across its consultancy division, enhancing operational efficiency and resilience. Additionally, Science Group is actively engaging with Ricardo PLC, where it holds a 20.08% share, to address strategic and governance concerns, leading to the requisition of a general meeting.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
May 21, 2025

Science Group PLC, a company listed on the AIM market, announced the repurchase of 5,000 of its ordinary shares at a price of 476.0 pence per share. This transaction represents a minor portion of the company’s voting rights and will be held in treasury, adjusting the total number of shares in issue. This move is part of the company’s ongoing buyback program, which may impact shareholder calculations under FCA regulations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
May 16, 2025

Science Group PLC announced the repurchase of 7,500 of its ordinary shares at a price of 458.0 pence per share, representing 0.02% of the voting rights. These shares will be held in treasury, affecting the total number of shares in issue and potentially impacting shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group PLC Issues Treasury Shares to Settle Options
Neutral
May 12, 2025

Science Group PLC has issued 10,000 treasury shares at an average price of 1 pence per share to settle the exercise of share options. This action adjusts the total number of ordinary shares in issue to 44,567,805, excluding treasury shares, and holds implications for shareholder notifications under regulatory guidelines.

Business Operations and Strategy
Science Group PLC Issues Share Options to Key Employees
Positive
May 12, 2025

Science Group PLC has announced the issuance of share options over 260,000 ordinary shares to 26 employees as part of its annual option grant under the Performance Share Plan. These options will vest after three years, contingent on meeting specific Earnings per Share growth targets from 2025 to 2027, and are exercisable at a nominal value for seven years post-vesting. This move is part of the company’s strategy to incentivize and retain key personnel, potentially enhancing its competitive position in the market.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
May 8, 2025

Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 446.0 pence per share, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s buyback program and will result in the shares being held in treasury. The total number of ordinary shares in issue, excluding treasury shares, now stands at 44,557,805. This move may impact shareholders’ calculations regarding their interest in the company under FCA’s regulations.

Business Operations and StrategyFinancial Disclosures
Science Group Calls for Strategic Overhaul at Ricardo Amid Financial Struggles
Negative
May 1, 2025

Science Group PLC, a major shareholder in Ricardo plc, has raised concerns about Ricardo’s strategic direction and financial performance. Despite being the second-largest shareholder with a 20.08% stake, Science Group criticizes Ricardo’s recent Business & Strategy Update for failing to address key financial challenges and for not providing a clear path to recovery. The update highlighted a significant downgrade in financial forecasts, including a projected loss in operating profit and reduced cash flow, which has led to a call for leadership changes at Ricardo. Science Group is advocating for a strategic review and possible restructuring of Ricardo to restore shareholder value, while also considering potential sale options due to the company’s deteriorating financial position.

Regulatory Filings and Compliance
Science Group PLC Announces Total Voting Rights and Share Capital Details
Neutral
May 1, 2025

Science Group PLC has announced its total issued share capital, excluding treasury shares, which consists of 44,562,805 shares of 1 penny each. The company holds 1,623,069 shares in treasury. This information is crucial for shareholders as it helps them determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting their interest calculations in the company.

Stock BuybackBusiness Operations and Strategy
Science Group PLC Executes Share Buyback
Neutral
Apr 30, 2025

Science Group PLC has executed a share buyback, purchasing 2,893 of its ordinary shares at an average price of 438.5 pence per share. This transaction represents a minor portion of the company’s total voting rights and is part of a strategic move to manage its share capital. The shares will be held in treasury, adjusting the total number of shares available for shareholder calculations under regulatory guidelines.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Apr 29, 2025

Science Group PLC announced the repurchase of 5,000 ordinary shares at a price of 445.0 pence per share, representing 0.01% of the voting rights. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,565,698. This buyback may influence shareholder calculations regarding their interest in the company, as per FCA’s Disclosure Guidance and Transparency Rules.

Business Operations and StrategyFinancial Disclosures
Science Group Reports Strong Q1 Amid Criticism of Ricardo’s Strategy
Negative
Apr 24, 2025

Science Group PLC reported a strong start to 2025 with revenue and profitability slightly exceeding expectations, despite volatile market conditions. The company highlighted its robust balance sheet and strong operating cash flow. In contrast, Science Group criticized Ricardo PLC, where it holds a significant share, for poor financial management and lack of strategic clarity, which has led to a significant decline in shareholder value. Science Group’s engagement has prompted some acknowledgment of issues by Ricardo’s board, but the latter’s performance remains underwhelming compared to its peers.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Apr 24, 2025

Science Group PLC has repurchased 7,500 of its ordinary shares at a consistent price of 413.0 pence per share, representing 0.02% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s ongoing share buyback program, potentially impacting shareholder calculations under the FCA’s rules.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Apr 23, 2025

Science Group PLC announced the repurchase of 9,500 of its ordinary shares at an average price of 415.79 pence per share, as part of its ongoing share buyback program. This transaction represents 0.02% of the voting rights and will see the shares held in treasury, adjusting the total number of shares in issue to 44,578,198. This move may influence shareholder calculations regarding their interests in the company under regulatory guidelines.

Stock Buyback
Science Group Announces Share Buyback
Neutral
Apr 22, 2025

Science Group plc, a company listed on the AIM market, announced the repurchase of 5,000 of its ordinary shares at a price of 418.0 pence each. This transaction represents a small fraction of the company’s total voting rights and is part of a buyback program executed through Panmure Liberum Limited. The repurchased shares will be held in treasury, affecting the total number of shares available for shareholder calculations under regulatory guidelines.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Apr 17, 2025

Science Group PLC announced the repurchase of 5,000 of its ordinary shares at an average price of 414.5 pence per share, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program, with the purchased shares held in treasury. The total number of ordinary shares in issue, excluding treasury shares, is now 44,592,698. This move may impact shareholder calculations regarding their interests in the company under FCA rules.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Apr 16, 2025

Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 415.0 pence per share, which will be held in treasury. This transaction represents 0.01% of the voting rights of the total ordinary shares, and the updated number of shares in issue is 44,597,698. This move is part of the company’s buyback program and may impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 12, 2025